CNS Pharmaceuticals, Inc.
CNSP
$4.59
-$0.30-6.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.78% | -87.50% | 42.59% | 6.16% | -21.34% |
| Total Depreciation and Amortization | 72.73% | 0.00% | -12.50% | 37.50% | 37.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.83% | -32.56% | -97.87% | -90.70% | -69.22% |
| Change in Net Operating Assets | -71.48% | 216.08% | 149.70% | -563.54% | 567.94% |
| Cash from Operations | -43.39% | 44.22% | 68.03% | -223.76% | -1.56% |
| Capital Expenditure | -- | -333.33% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -333.33% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.70% | 1.28% | 1.19% | 1.11% | 0.91% |
| Issuance of Common Stock | -94.45% | -89.98% | -99.99% | 85.53% | 154.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -541.00% | 96.25% | 100.00% | -- |
| Cash from Financing | -95.88% | -91.80% | -100.75% | 90.21% | 184.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -164.53% | -420.44% | -141.33% | -235.69% | 2,371.37% |